|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 16/40 | (2013.01) |
| C07K 16/40 | (2006.01) | ||
| C07K 14/725 | (2006.01) | ||
| A61K 35/00 | (2013.01) | ||
| C12N 5/0783 | (2010.01) | ||
| C12N 9/16 | (2013.01) | ||
| A61K 35/17 | (2015.01) | ||
| C12Y 301/03001 | (2013.01) | ||
| A61K 35/00 | (2006.01) | ||
| G01N 33/57407 | (2013.01) | ||
| C07K 16/28 | (2006.01) | ||
| C07K2319/30 | (2013.01) | ||
| C12N 9/16 | (2006.01) | ||
| A61K 47/6803 | (2017.08) | ||
| G01N 33/574 | (2006.01) | ||
| A61K 47/6871 | (2017.08) | ||
| A61P 35/00 | (2018.01) | ||
| A61K 39/00 | (2006.01) | ||
| A61K 47/68 | (2017.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Patento numeris | 3383920 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 16871367.5 |
| Europos patento paraiškos padavimo data | 2016-11-29 | |
| (97) | Europos patento paraiškos paskelbimo data | 2018-10-10 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2024-01-10 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2016/064033 |
| Data | 2016-11-29 |
| (87) | Numeris | WO 2017/095823 |
| Data | 2017-06-08 |
| (30) | Numeris | Data | Šalis |
| 201562261112 P | 2015-11-30 | US |
| (72) |
LIU, Bin , US
BIDLINGMAIER, Scott , US
SU, Yang , US
|
| (73) |
The Regents of the University of California ,
1111 Franklin Street, 12th Floor, Oakland, CA 94607-5200,
US
|
| (54) | TUMOR-SPECIFIC PAYLOAD DELIVERY AND IMMUNE ACTIVATION USING A HUMAN ANTIBODY TARGETING A HIGHLY SPECIFIC TUMOR CELL SURFACE ANTIGEN |
| TUMOR-SPECIFIC PAYLOAD DELIVERY AND IMMUNE ACTIVATION USING A HUMAN ANTIBODY TARGETING A HIGHLY SPECIFIC TUMOR CELL SURFACE ANTIGEN |